Research
ELRIG Therapeutic Oligonucleotides 2025
The second ELRIG meeting on Therapeutic Oligonucleotides, scheduled for May 14-15, 2025, will be hosted at the AstraZeneca R&D site in Gothenburg. This dynamic event aims to build upon the success of the inaugural Therapeutic Oligonucleotides meeting and the well-regarded Advances i...
Applications are open for Catalyser 2025, SBC's free accelerator programme
Are you a pre-clinical therapeutics start-up? Stevenage Bioscience Catalyst’s Catalyser programme is an accelerator designed to help businesses attract investors and partners, and maximise overall chances of commercial success. ...
Milner Institute hosts official opening of new Functional Genomics Screening Laboratory
The new Functional Genomics Screening Laboratory will support world-class research and innovation in the rapidly advancing field of functional genomics, which explores links between genes and disease. ...
A new approach to tackle children's mental health
How long should a child have to wait for mental health support? Acteon, Cambridge BPI and the University of Cambridge to provide 11-18 year olds with supportive, scientifically backed resources while they wait. ...
ELRIG announces Prof Rory Johnson and Dr Shalini Andersson as Keynote Speakers at Therapeutic Oligonucleotides 2025
Therapeutic Oligonucleotides 2025: Drugging the Undruggable takes place at AstraZeneca in Gothenburg, Sweden from 14–15 May ...
Acne vulgaris vaccines: time for something new
This month VacZine Analytics, a specialist in infectious diseases and vaccines commercial analysis, publishes a brand-new global analysis focused on the potential for acne vulgaris vaccines. ...
Finding Clarity, Support and Momentum as an Innovation Entrepreneur
By Garry Jennings, Innovation Director, The EpiCentre
Cambridge scientist launches free VR platform that eliminates the fear of public speaking
Dr Chris Macdonald creates free virtual reality platform that transforms users into skilled and confident public speakers ...
Living with Pulmonary Arterial Hypertension: Early Diagnosis, Patient Advocacy, and the Role of Technology
Co-authored by Maleen Fischer, PHA Europe